Evidence map›Paper›PMID 41229719›Full record

ReviewIndian journal of endocrinology and metabolism

A Glimpse into the Realm that Combines Artificial Intelligence and Endocrinology.

Minal Pande, Shinjan Patra, Soubhik Rudra, Naila Khan, Kishore K Katam, Avinash Ramteke

Abstract readReview
In one paragraph

Review in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Minal PandeDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Shinjan PatraDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
Soubhik RudraDepartment of Generative AI Developer, Tata Consultancy Service, International Financial Hub (CBD), Newtown, Kolkata, West Bengal, India.
Naila KhanDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Kishore K KatamDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Avinash RamtekeDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial Intelligence (AI) in the healthcare sector is expanding quickly. It is significantly assisting us in assimilating the growing volume of data and applying it to enhance patient care while maintaining the present state of cost-effectiveness. AI has often been used in developing screening and diagnostic tools in endocrinology, with some limited uses in disease management. AI has assisted in the accurate diagnosis of thyroid nodules, detection of adrenal malignancies, prediction of diabetes microvascular complications, calculation of correct bone age, and estimation of the risks of osteoporosis. Additionally, it has been used successfully in the insulin algorithm of closed-loop insulin delivery and predicting survival in endocrinological malignancies. With an emphasis on the key concepts of artificial intelligence, such as machine learning algorithms and deep-learning models, this article seeks to present a brief overview of the state of AI applications in endocrinology and metabolism.

Indexed as

Artificial intelligencedeep learningendocrinologymachine learningrisk prediction

Identifiers

PMID41229719
PMCPMC12604839

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.